Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002).

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-03044
Affiliations:
10
Authors:
21
Go to article
Institutions Authors Share
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China
8.000000
 0.38
State Key Laboratory of Oncology in South China, SYSUCC, China
8.000000
 0.38
SYSU-CAS Holdings United Laboratory of Frontier Radiotherapy Technology, China
1.000000
 0.05
Zhongshan City People's Hospital, China
1.000000
 0.05
Jieyang People's Hospital, China
1.000000
 0.05
The First Affiliated Hospital, SYSU, China
1.000000
 0.05
Charité - University Medicine Berlin, Germany
0.500000
 0.02
Berlin Institute of Health (BIH), Germany
0.500000
 0.02
Interested in Oncology and Carcinogenesis?